Men at 'high' skeletal risk prior to prostate cancer hormone therapy likely to have more fractures after treatment
Thursday, January 17, 2013 - 23:30
in Health & Medicine
In what is believed to be the first study to describe the impact on men with a ‘high’ risk of bone fracture who are receiving long-term androgen deprivation therapy (ADT) for prostate cancer, new research shows this population to have a higher fracture incidence following treatment completion.